Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Blood. 2012 Sep 27;120(13):2610-9. doi: 10.1182/blood-2012-06-434779. Epub 2012 Aug 14.
Interleukin-7 (IL-7) is a nonredundant cytokine that plays a critical role in T-cell homeostasis and promotes immunologic reconstitution in lymphopenic hosts. Here, we show that IL-7, at doses that reflect suprahomeostatic concentrations achieved in lymphopenic hosts, is a potent and selective inducer of the gut-homing integrin α4β7 in human T cells, as documented both ex vivo and in vivo in patients enrolled in a clinical trial of IL-7 treatment. Induction of α4β7 by IL-7 occurs primarily in naive T cells and is associated with functional activation of the integrin, as indicated by increased binding activity for the specific α4β7 ligand, MAdCAM-1. The physiologic relevance of these findings was validated by the preferential homing of IL-7-treated naive human T cells to the intestinal compartment in humanized NOD/SCID/IL-2 receptor-γ(null) (NSG) mice. We also show that IL-7 triggers a peculiar activation program in naive T cells, characterized by the acquisition of memory-like phenotypic features and proliferation uncoupled from expression of classic T-cell activation markers. These findings provide a mechanism for the transient in vivo depletion of circulating T cells after IL-7 administration and suggest that intestinal homing and memory-like conversion of naive T cells are critical steps in the IL-7-driven immunologic reconstitution of lymphopenic hosts.
白细胞介素-7(IL-7)是一种非冗余细胞因子,在 T 细胞稳态中起着关键作用,并促进淋巴缺失宿主的免疫重建。在这里,我们表明,IL-7 在剂量上反映了在淋巴缺失宿主中达到的超稳态浓度,是人类 T 细胞中肠道归巢整合素 α4β7 的有效和选择性诱导剂,这在临床试验中接受 IL-7 治疗的患者的体内和体外都有记录。IL-7 诱导的 α4β7 主要发生在幼稚 T 细胞中,并与整合素的功能激活相关,这表现为对特定的 α4β7 配体 MAdCAM-1 的结合活性增加。这些发现的生理相关性通过经 IL-7 处理的幼稚人 T 细胞在人源化 NOD/SCID/IL-2 受体-γ(null)(NSG)小鼠中优先归巢到肠道隔室得到验证。我们还表明,IL-7 在幼稚 T 细胞中引发了一种特殊的激活程序,其特征是获得记忆样表型特征,以及与经典 T 细胞激活标志物表达脱耦联的增殖。这些发现为 IL-7 给药后循环 T 细胞体内短暂耗竭提供了一种机制,并表明肠道归巢和幼稚 T 细胞的记忆样转化是 IL-7 驱动的淋巴缺失宿主免疫重建的关键步骤。